Use of Disease-Modifying Therapies in Pediatric MS

Title
Use of Disease-Modifying Therapies in Pediatric MS
Authors
Keywords
Pediatric, Multiple sclerosis, Treatment, Interferon, Glatiramer acetate, Monoclonal antibody, Relapse, Disability, Cognition, Safety, Efficacy, Randomized controlled trial
Journal
Current Treatment Options in Neurology
Volume 18, Issue 8, Pages -
Publisher
Springer Nature
Online
2016-06-17
DOI
10.1007/s11940-016-0420-7

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started